Showing posts with label mRNA. Show all posts
Showing posts with label mRNA. Show all posts

Monday, August 15, 2022

How the CDC Alters its Narrative to Align with the Facts

One of the keys to solving the pandemic has been the use of a brand new vaccine technology called messenger RNA better known to most of us as mRNA.  This technology works as follows according to the CDC:

 


Here's another collection of graphics from the European Vaccination Information Portal showing how the mRNA vaccines work:

 




Note this phrase from the second graphic:

 

"The proteins and the mRNA are destroyed and disappear from your body in a matter of days."

  

Here's another graphic from the New York City government with the same information:

 


This narrative has been promoted heavily during the vaccination phase of the pandemic, largely to reassure the COVID-19 vaccine consumers that the mRNA technology would not alter human DNA as shown here:

 


As the purveyor of health information to the American public and as one of the world's most influential medical institutions, narratives from the Centers for Disease Control and Prevention or CDC carry a lot of weight globally.  Here's what the CDC had to say about the persistence of mRNA in the human body on July 22, 2022:

 

The next day, this is what the CDC had to say about the persistence of mRNA after vaccination:

 

 

Is the CDC now recanting on a key part of its COVID-19 mRNA vaccine safety claims that were being used to coerce humans into accepting the vaccines as "safe"?  


The CDC has now completely removed its guidance on the persistence of mRNA and the spike proteins generated by the COVID-19 vaccines which had been part of its narrative going back to November 2020 before the mRNA vaccines had even rolled out and were still being tested by their manufacturers as shown here:

 

Apparently, in the CDC's world, if facts don't align with the narrative, you simply change the "facts" on your website, hoping that the world doesn't notice.  George Orwell would be so delighted to see that his vision of the future has come true as quoted here:

 

"Every record has been destroyed or falsified, every book has been rewritten, every picture has been repainted, every statue and street and building has been renamed, every date has been altered. And that process is continuing day by day and minute by minute. History has stopped. Nothing exists except an endless present in which the Party (or CDC) is always right."


Wednesday, September 15, 2021

Moderna's COVID-19 Vaccine, Breakthrough Infections and Lining Up for a Booster

Just in case you thought that Pfizer's mRNA vaccine was the only one to see waning protection, Moderna has now released the results of a new analysis showing how its iteration of the COVID-19 vaccine stands up over time.


Here is the press release with my highlights:

 


Here are the pertinent highlights with my bolds:

 

Analysis of Open-Label Part of Phase 3 COVE Study (July-August 2021)

 

Today, Moderna is sharing a new analysis of the incidence of breakthrough COVID-19 cases among vaccinated participants in the open-label portion of the Phase 3 COVE study between July 1, 2021 and August 27, 2021. The goal of the analysis is to quantify the impact of waning immunity in the face of the Delta surge in the United States. The analysis compared participants initially randomized to mRNA-1273 (vaccinated from July-October 2020; n=14,746; median follow-up of 13 months since first dose) against participants initially randomized to placebo who were crossed over and vaccinated following Emergency Use Authorization (vaccinated from December 2020-March 2021; n=11,431; median follow-up of 8 months since first dose).

 

In the analysis, 88 breakthrough cases of COVID-19 occurred in the more recently vaccinated group (49.0 cases per 1000 person-years) compared to 162 cases in the group vaccinated last year (77.1 cases per 1000 person-years). The reduction in incidence rates for participants vaccinated more recently compared to participants vaccinated last year was 36% (95% CI: 17-52%). A Cox proportional hazards model showed similar results after adjusting for age and risk factors for severe COVID-19. Fortunately, only 19 severe cases were observed. While not significant, there was a numerical trend towards a lower rate of severe cases in the group vaccinated more recently (3.3 per 1000 person-years) compared to the group vaccinated last year (6.2 per 1000 person-years).

 

And, here's the "money shot" (literally):

 

"The increased risk of breakthrough in this analysis quantifies the impact of waning immunity in the COVE study between the median follow-up time of 8 months and 13 months since first dose. The Company believes this adds to evidence of potential benefit of a booster dose of mRNA-1273. A manuscript has been submitted as a preprint to medRxiv and will be submitted for peer-reviewed publication."

 

This begs the question; how will governments that are insisting upon the issuance of vaccine passports going to handle this?  Are the number of vaccines required to receive a passport going to keep increasing as research shows that the "protection" offered by the mRNA vaccines wanes over time?

 

Of course, Moderna has to "keep up with the Joneses" aka Pfizer in advocating for booster doses.  After all, what a great way to add billions of dollars of profit to the company's bottom line not to mention billions in wealth to the company's insiders!  That way, the mRNA vaccine money printing machine can keep churning out profits for the company's corner office dwellers who have seen Moderna's stock do this over the past five years:

 

 

Moderna shareholders and insiders that invested during the company's lean years (stock was sub $20) have now seen a 2170 percent return on their investment.  Lucky Bill Gates:


Just for fun and in closing, I read through the "Important Safety Information" on Moderna's press release and found these gems, many of which fly in the face of the advice being touted by public health officials and politicians who are pushing a 100 percent vaccinated mantra:

 

1.) Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished response to the Moderna COVID-19 Vaccine.


2.) The Moderna COVID-19 Vaccine may not protect all vaccine recipients.


3.) Available data on Moderna COVID-19 Vaccine administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy. Data are not available to assess the effects of Moderna COVID-19 Vaccine on the breastfed infant or on milk production/excretion.


4.) There are no data available on the interchangeability of the Moderna COVID-19 Vaccine with other COVID-19 vaccines to complete the vaccination series. Individuals who have received one dose of Moderna COVID-19 Vaccine should receive a second dose of Moderna COVID-19 Vaccine to complete the vaccination series.


5.) Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Moderna COVID-19 Vaccine.


Monday, March 29, 2021

Moderna and mRNA Vaccine Research

While Moderna continues the human-wide, government-promoted and mandated Phase 3 trials of its unprecedented mRNA-1273 COVID-19 vaccine, the company appears to be putting significant effort into advancing its mRNA-based vaccine research inventory.  

 

Here is how Moderna defines mRNA (messenger RNA):

 

"Messenger RNA, or mRNA, plays a fundamental role in human biology, transferring the instructions stored in DNA to make the proteins required in every living cell. mRNA provides instructions to cells to make protein. Moderna’s approach is to use mRNA medicines to instruct a patient’s own cells to produce proteins that could prevent, treat, or cure disease. We are also working to advance the development mRNA therapeutics that restore the activity of missing enzymes responsible for various rare diseases, such as methylmalonic acidemia (MMA) and propionic acidemia (PA)."

  

Messenger RNA vaccines are a completely new line of vaccines.  Here is some background information on mRNA vaccines from Harvard Health Blog

 

"The main goal of a vaccine for a particular infectious agent, such as the virus that causes COVID-19, is to teach the immune system what that virus looks like. Once educated, the immune system will vigorously attack the actual virus, if it ever enters the body.

 

Viruses contain a core of genes made of DNA or RNA wrapped in a coat of proteins. To make the coat of protein, the DNA or RNA genes of the virus make messenger RNA (mRNA); the mRNA then makes the proteins. An mRNA of a specific structure makes a protein of a specific structure.

 

About 30 years ago, a handful of scientists began exploring whether vaccines could be made more simply. What if you knew the exact structure of the mRNA that made the critical piece of a virus’s protein coat, such as the spike protein of the COVID-19 virus?

 

It is relatively easy to make that mRNA in the laboratory, in large amounts. What if you injected that mRNA into someone, and the mRNA then traveled through the bloodstream to be gobbled up by immune system cells, and then those cells started to make the spike protein? Would that educate the immune system?

 

While the concept seems simple, it required decades of work for mRNA vaccines to overcome a series of hurdles. First, scientists learned how to modify mRNA so that it did not produce violent immune system reactions. Second, they learned how to encourage immune system cells to gobble up the mRNA as it passed by in the blood. Third, they learned how to coax those cells to make large amounts of the critical piece of protein. Finally, they learned how to enclose the mRNA inside microscopically small capsules to protect it from being destroyed by chemicals in our blood.

 

Along the way, they also learned that, compared to traditional vaccines, mRNA vaccines can actually generate a stronger type of immunity: they stimulate the immune system to make antibodies and immune system killer cells — a double strike at the virus."

 

Here is a diagram from Moderna showing how its mRNA vaccines work:

 

Here is a video from Moderna featuring the company's president Dr. Stephen Hoge and its Chief Scientific Officer Paolo Martini on how Moderna is delivering on its mRNA therapies:

 


Now, let's look at Moderna's current research on mRNA vaccines, most of which are still in Phase 1 or 2 clinical study with the notable exception of the COVID-19 mRNA-1273 vaccine:  

 

Who is backing this research?  Here's the answer:

 

 

Shocking, isn't it?   In "Gatesworld" there's nothing that can't be solved with a heavy dose of technology and a hefty influx of a seemingly endless bundle of cash.

 

Let's close with this information from the Centers for Disease Control and Prevention on mRNA vaccines:

 

"There are currently no licensed mRNA vaccines in the United States. However, researchers have been studying them for decades.

 

Early stage clinical trials using mRNA vaccines have been carried out for influenza, Zika, rabies, and cytomegalovirus (CMV). Challenges encountered in these early trials included the instability of free RNA in the body, unintended inflammatory outcomes, and modest immune responses. Recent technological advancements in RNA biology and chemistry, as well as delivery systems, have mitigated these challenges and improved their stability, safety, and effectiveness.

 

Beyond vaccines, numerous preclinical and clinical studies have used mRNA to encode cancer antigens to stimulate immune responses targeted at clearing or reducing malignant tumors."

 

Given that mRNA vaccines are unprecedented and that Moderna's mRNA-1273 vaccine is not scheduled to complete its phase 3 clinical trial until October 27, 2022 as shown here:

 

...we are all unwitting animal test subjects in the very early days of a new unproven technology.